Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation
June 19, 2018 08:00 ET
|
Aphios
WOBURN, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it and the LSU Health Shreveport Department of Molecular & Cellular Physiology have been granted United...
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st
June 14, 2018 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., June 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Chronic and Rare Disease Groups Raise Alarm About California Bill that Threatens Access to Insurance Coverage for Kidney Patients
June 08, 2018 10:00 ET
|
American Kidney Fund
ROCKVILLE, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Thirteen groups representing patients with chronic and rare diseases have joined the American Kidney Fund and others in opposition to California...
LogistiCare and National Kidney Foundation Join to End Kidney Disease
May 22, 2018 11:29 ET
|
LogistiCare
Atlanta, GA, May 22, 2018 (GLOBE NEWSWIRE) -- The National Kidney Foundation of Georgia hosted the 2018 Atlanta Kidney Walk on Saturday, May 19 at Atlantic Station in Midtown Atlanta. Thousands of...
Proteon Therapeutics Announces First Quarter 2018 Financial Results
May 09, 2018 08:10 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial Supply
May 08, 2018 07:00 ET
|
Proteon Therapeutics, Inc.
Partners extend existing contract for manufacture of vonapanitase to 2029 as ongoing Phase 3 trial nears completionLonza Pharma & Biotech successfully scaled up a lab process at their Microbial...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results
March 14, 2018 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
March 06, 2018 16:45 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase
March 05, 2018 17:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15th
November 08, 2017 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...